Literature DB >> 23266150

The effect of levetiracetam on neuronal apoptosis in neonatal rat model of hypoxic ischemic brain injury.

Hasan Kilicdag1, Kenan Daglıoglu, Seyda Erdogan, Aslan Guzel, Leman Sencar, Sait Polat, Suzan Zorludemir.   

Abstract

BACKGROUND: Hypoxic-ischemic brain injury (HIBI) is a common cause of neonatal mortality and morbidity. The use of levetiracetam (LEV), as a potential neuroprotective in brain ischemia, receives an increasingly high attention, and it could have a crucial role in the regulation of epileptogenesis and neuroprotection. Potential effects of LEV on neuronal apoptosis in HIBI have not previously been reported in literature.
OBJECTIVES: The aim of this study is to evaluate the possible effects of LEV on neuronal apoptosis in neonatal rat model of HIBI.
METHODS: Seven-day-old Wistar rat pups were subjected to right common carotid artery ligation and hypoxia (92% nitrogen and 8% oxygen) for 2h. The pups were treated with LEV or saline after hypoxia. In sham group rats, neither ligation, nor hypoxia was performed. Neuronal apoptosis was evaluated by the terminal deoxynucleotidyl-transferase- mediated dUTP nick-end labeling (TUNEL) methods.
RESULTS: The counts of apoptotic cells in both hippocampus and cerebral cortex were significantly higher in the saline treatment group than in the sham group. The counts of apoptotic cells in both hippocampus and cerebral cortex were similar to those in the sham group and in the LEV treatment group. The number of apoptotic cells decreased significantly in the LEV-treated group compared with the saline group.
CONCLUSIONS: These results show that LEV administration after hypoxia reduces neuronal apoptosis. Thus, we propose that LEV, as an effective antiepileptic and antiapoptotic drug, may be a viable choice for the control of seizure activity in neonates with HIBI.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23266150     DOI: 10.1016/j.earlhumdev.2012.12.002

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  26 in total

Review 1.  Pharmacotherapy for Seizures in Neonates with Hypoxic Ischemic Encephalopathy.

Authors:  Elissa Yozawitz; Arthur Stacey; Ronit M Pressler
Journal:  Paediatr Drugs       Date:  2017-12       Impact factor: 3.022

2.  Pretreatment with baicalin attenuates hypoxia and glucose deprivation-induced injury in SH-SY5Y cells.

Authors:  Qing-bo Zhou; Xiao-ning Ju; Xiao-yun Wang; Mei-hong Wang; Feng Kong; Chao Sun; Jian-zhong Bi
Journal:  Chin J Integr Med       Date:  2015-12-19       Impact factor: 1.978

3.  Initial Treatment for Nonsyndromic Early-Life Epilepsy: An Unexpected Consensus.

Authors:  Renée A Shellhaas; Anne T Berg; Zachary M Grinspan; Courtney J Wusthoff; John J Millichap; Tobias Loddenkemper; Jason Coryell; Russell P Saneto; Catherine J Chu; Sucheta M Joshi; Joseph E Sullivan; Kelly G Knupp; Eric H Kossoff; Cynthia Keator; Elaine C Wirrell; John R Mytinger; Ignacio Valencia; Shavonne Massey; William D Gaillard
Journal:  Pediatr Neurol       Date:  2017-06-27       Impact factor: 3.372

4.  Comparative Effectiveness of Levetiracetam vs Phenobarbital for Infantile Epilepsy.

Authors:  Zachary M Grinspan; Renée A Shellhaas; Jason Coryell; Joseph E Sullivan; Elaine C Wirrell; John R Mytinger; William D Gaillard; Eric H Kossoff; Ignacio Valencia; Kelly G Knupp; Courtney Wusthoff; Cynthia Keator; Nicole Ryan; Tobias Loddenkemper; Catherine J Chu; Edward J Novotny; John Millichap; Anne T Berg
Journal:  JAMA Pediatr       Date:  2018-04-01       Impact factor: 16.193

5.  Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial.

Authors:  Cynthia Sharpe; Gail E Reiner; Suzanne L Davis; Mark Nespeca; Jeffrey J Gold; Maynard Rasmussen; Rachel Kuperman; Mary Jo Harbert; David Michelson; Priscilla Joe; Sonya Wang; Neggy Rismanchi; Ngoc Minh Le; Andrew Mower; Jae Kim; Malcolm R Battin; Brian Lane; Jose Honold; Ellen Knodel; Kathy Arnell; Renee Bridge; Lilly Lee; Karin Ernstrom; Rema Raman; Richard H Haas
Journal:  Pediatrics       Date:  2020-05-08       Impact factor: 7.124

Review 6.  Levetiracetam in neonatal seizures: a review.

Authors:  Allison L Mruk; Karen L Garlitz; Noelle R Leung
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Mar-Apr

7.  Orexin-A promotes Glu uptake by OX1R/PKCα/ERK1/2/GLT-1 pathway in astrocytes and protects co-cultured astrocytes and neurons against apoptosis in anoxia/hypoglycemic injury in vitro.

Authors:  Qing Shu; Jianhuai Zhang; Wei Ma; Youying Lei; Dan Zhou
Journal:  Mol Cell Biochem       Date:  2016-11-12       Impact factor: 3.396

8.  Levetiracetam Compared to Phenobarbital as a First Line Therapy for Neonatal Seizures: An Unexpected Influence of Benzodiazepines on Seizure Response.

Authors:  Charlotte B Wagner; Alexander M Kreimer; Nina P Carrillo; Elizabeth Autry; Aric Schadler; Aaron M Cook; Noelle R Leung
Journal:  J Pediatr Pharmacol Ther       Date:  2021-02-15

Review 9.  Neonatal seizures: advances in mechanisms and management.

Authors:  Hannah C Glass
Journal:  Clin Perinatol       Date:  2013-12-12       Impact factor: 3.430

10.  Neuroprotective effect of levetiracetam on hypoxic ischemic brain injury in neonatal rats.

Authors:  Mustafa Komur; Cetin Okuyaz; Yalcin Celik; Bora Resitoglu; Ayse Polat; Senay Balci; Lulufer Tamer; Semra Erdogan; Huseyin Beydagi
Journal:  Childs Nerv Syst       Date:  2014-02-14       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.